Historical record - last NADAC effective date: 12/17/2014
Product Information
CLARITIN 10 MG REDITABS is a brand product labeled by Bayer HealthCare LLC, priced at $0.7764 per EA under NDC 11523715703. Its NADAC has been published 53 times since Nov 28, 2013.
FDA first approved this application on Nov 27, 2002.
The High Outlier badge above means this manufacturer's average price in the Loratadine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Bayer HealthCare LLCNDC
11523715703
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
12/17/2014
Active Ingredients
LORATADINEApproval Type
New Drug (NDA)
FDA Application
NDA020704FDA Approved
11/27/2002
On Market Since
11/27/2002
Price Statistics
The NADAC for CLARITIN 10 MG REDITABS has been published 53 times since Nov 28, 2013, and over the history we have for it it has declined 4.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7764 per EA |
|---|---|
| All-time high | $0.8489 (Jul 16, 2014) |
| All-time low | $0.6138 (Sep 17, 2014) |
| Median price | $0.8127 |
| Average price | $0.7940 |
| Largest weekly change | -25.8% (Sep 17, 2014) |
| Weeks tracked | 53 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-4.5%
Last surveyed Dec 31, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLARITIN 10 MG REDITABS?
The current National Average Drug Acquisition Cost (NADAC) for CLARITIN 10 MG REDITABS, manufactured by Bayer HealthCare LLC, is $0.7764 per EA (NDC 11523715703), effective Dec 31, 2014.
How has the price of CLARITIN 10 MG REDITABS changed over time?
Over the history we have for it, the NADAC for CLARITIN 10 MG REDITABS has declined 4.5%. It has been tracked across 53 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARITIN 10 MG REDITABS?
Since Nov 28, 2013, the NADAC for CLARITIN 10 MG REDITABS has ranged from a low of $0.6138 (Sep 17, 2014) to a high of $0.8489 (Jul 16, 2014), with a median of $0.8127 per EA.
Are there cheaper alternatives to CLARITIN 10 MG REDITABS?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORATADINE 10 MG TABLET, is $0.0532 per EA — about 93% below CLARITIN 10 MG REDITABS.
Who manufactures CLARITIN 10 MG REDITABS?
CLARITIN 10 MG REDITABS (NDC 11523715703) is labeled by Bayer HealthCare LLC, and CMS classifies it as a brand product.